Members area login

Username

Password

Remember

Please enter your email address

 

Please enter your membership ID (optional)

 
Follow Cephalalgia
Follow IHS
LATEST NEWS

Board & committees

Board of Trustees

The 12 members of the Board of Trustees include the four Officers of the Society (President, President-elect, Treasurer and Secretary). The President, President-elect and six Trustees are elected by the membership; three Trustees are appointed to add under-represented perspectives and/or specific expertise to the Board. The elected members are elected to 2-year terms of office by the membership during the AGM held during the International Headache Congress, automatically renewable for a second 2-year term. Any standard member of the Society may be nominated to join the Board of Trustees. Additional Trustees can be Co-opted by the Board to serve a 2-year term.

Standing Committees and Special Interest Groups

The Society's 20 Standing Committees and Special Interest Groups each have a specific role and advise the Board of Trustees on particular aspects of the business and/or functions of the Society. Each has a Chairman appointed by the Board of Trustees who must be a member of the Society. There are standing and ad-hoc Standing Committees. Both have prescribed areas of responsibility, standing committees remaining permanently in place with continuous activities or functions, ad-hoc being reconstituted from time to time to carry out particular initiatives. The Linguistic Special Interest Groups have more general responsibility for promoting the Society's objectives amongst those whose first language is not English. Click on the individual Committees in the menu below for details of each Committee's aims and activities together with the names and contact details of the Chairmen and members.

Select individual committees from the drop-down menu for remit, members and activitites.

Advisory Council

The Advisory Council is comprised of the Chairmen of the Standing Committees and Special Interest Groups and the elected representatives of member National Societies. The Advisory Council meets annually to report their activities and give advice to the Board of Trustees. 

Task Forces

The Board of Trustees and Standing Committees can create Task Forces as required to undertake specific one-off time-limited activities.

 

Select from the drop down menu:

Advisory Council Members

BOARD OF TRUSTEES
President:

 
  • Messoud Ashina (Denmark)
    Institution: Danish Headache Center, Rigshospitalet Glostrup, University of Copenhagen
    Country: Denmark

    Messoud Ashina is Professor of Neurology in the Faculty of Health and Medical Sciences, University of Copenhagen, Denmark. He is also Director of the Human Migraine Research Unit at the Danish Headache Center and Department of Neurology, Rigshospitalet Glostrup.

    Professor Ashina has been actively involved in headache research since 1995. His research interests include experimental migraine and cluster headache models, functional neuroimaging, novel antimigraine drug targets, mechanism of migraine and action of antimigraine medications. He has authored over 400 papers, abstracts and book chapters on the topic of headache, including migraine and cluster headache.

    Messoud Ashina serves as associate editor of Cephalalgia, associate editor of Headache and co-editor of The Journal of Headache and Pain. Professor Ashina is President of the International Headache Society and General Secretary of the European Headache Federation.

    Disclosures

    Scientific journals: Associate Editor of Cephalalgia, Co-Editor of Journal of Headache and Pain, Associate Editor of Headache.
    Organizations: General Secretary of the European Headache Federation, member of the European Academy of Neurology Scientific Panel on Headache
    Consulting: Allergan, Amgen, Eli Lilly, Lundbeck, Novartis, Percept and Teva
    Principal investigator (ongoing): Amgen, Allergan, Eli Lilly, Novartis
    Research grants: Lundbeck Foundation, Novartis, Novo Nordisk Foundation


President-Elect:
 
  • Cristina Tassorelli (Italy)
    Institution: Neurological Institute C Mondino Foundation
    Country: Italy

    Director of the Headache Science Centre and of the Neurorehabilitative Unit at the IRCCS C. Mondino Foundation
    Chair of Neurology,  Director of the Neurology Residency Program and Vice-director of the Department of Brain and Behavioral Sciences at the University of Pavia.
     
    Dr Tassorelli received a medical degree summa cum laude from the University of Pavia. She was an intern at the C. Mondino National Neurological Institute as part of her MD training, completed her training in Neurology at the University of Pavia and then obtained a PhD Degree in Human Psychobiology at the University of Modena (Italy). She spent a 2-year Post-Doctoral Fellowship at the Dept. of Neuroscience of the University of Rochester (NY).

    She has served as a director in the Board of the International Headache Society, Chair of the IHS Committee for the Guidelines of Clinical Trials  and is presently President-elect.
    She was a founding member and vice-President of the European Headache Alliance.
    She is presently Chief Section Editor of Frontiers in Neurology, section Headache Medicine and Facial Pain.

    She has been the coordinator and/or a partner in competitive grants funded by the EU, the Migraine Research Foundation, the Italian Ministry of Health and the Italian Ministry of University.
    Dr. Tassorelli has authored more than 270 peer-reviewed publications and coauthored several books and book chapters.

    Disclosures

    Fees for lecturing and participation in Advisory Boards from Allergan, electroCore, Eli Lilly, Novartis, Teva and Biohaven
    PI or Collaborator for clinical trials sponsored by electroCore, Allergan, Novartis, Teva and Eli Lilly

     


Honorary Secretary:
 
  • Stefan Evers (Germany)
    Institution: University of Münster and Krankenhaus Lindenbrunn
    Country: Germany

    Stefan Evers received his MD in medicine and his PhD in musicology at the University of Münster, Germany. After training in general neurology including 1 year of research at the Institute of Neurology, London, he became consultant and Professor of Neurology at the Department of Neurology, University of Münster. In 2012 he became Head of the Neurological Hospital "Lindenbrunn".

    Stefan Evers was President of the German Migraine and Headache Society from 2003 to 2007 and Chair of the Headache Panel of the European Federation of Neurological Societies from 2003 to 2010. Since 2015 he is Chair of the Headache Panel of the European Academy of Neurology. Since 2011 he has been Honorary General Secretary of the IHS.

    He has published more than 220 scientific papers and several book chapters and books on headache and migraine, pain research, and general clinical neurology. Besides pain, special fields of interest are epilepsy, stroke, neuromanifestations of HIV infection, and the neurobiology of music.

    Disclosures
    Honoraria for consulting: Allergan, Reckitt Benckiser, Johnson & Johnson, Lilly, Novartis, TEVA
    Speaker's honoraria: Allergan, Reckitt Benckiser, Lilly, Novartis, TEVA


Honorary Treasurer:
 
  • Wendy Thomas (UK)
    Country: UK

    Wendy Thomas is past Chief Executive of The Migraine Trust, the health and medical research charity for migraine in the United Kingdom. She is also a director and chair of the Migraine Trust International Symposium  Ltd. (appointed by The Migraine Trust), 

    She is currently Treasurer of the British Association for the Study of Headache (BASH).

    Ms Thomas' interests have been in charity governance and in particular the importance of the control of financial aspects of the organisation concerned. She works to ensure that the finances of IHS are on a sound footing and stay that way, and aims to make the finances to be transparent and therefore easy for the non-financial mind to understand.

    Disclosures
    Treasurer of British Association for the Study of Headache; Director and chair of the Migraine Trust International Symposium Ltd.


Past-President:
 
  • Lars Edvinsson (Sweden)
    Institution: University Hospital of Lund
    Country: Sweden

    Lars Edvinsson is currently Professor and senior consultant at Lund University/Hospital in Internal Medicine, MD PhD, and Chairman of the Swedish Migraine Society, on the board of EHF, immediate past president of IHS.

    In 2008 Lars Edvinsson was called to be professor at the Copenhagen University in "Receptor Regulation in Cerebrovascular and Cardiovascular Diseases" and in 2007 funded and is currently Director of the Glostrup Research Park, Copenhagen. In 2012 he received a Lifetime Achievement award from American Headache colleagues (Stowe, VT), and Honoray Dr Hon Causa in Szeged, Hungary.

    He has a long history in studies of the cerebral circulation, innervation, receptors and function. In 1984 He was the first to describe CGRP in cranial vessels and the trigeminal ganglion, showed the release of CGRP in conjunction with migraine and cluster headache attacks, and has been instrumental in the development of novel CGRP receptor antagonists. His current work is centered at finding lokalisation of CGRP family of receptors in cranial structures and in CNS in order to illustrate the possible sites of action of novel CGRP acting drugs. The work involves also studies of other possible migraine candidates such as PACAP and 5-HT subtype receptor expressions as well as studies of their interactions and functional roles.

    Disclosures
    Supported by companies for talks at different symposia and locally


Elected Trustees:
 
  • Fayyaz Ahmed (UK)
    Institution: Hull Royal Infirmary
    Country: UK

    Dr Fayyaz Ahmed is a Consultant Neurologist and Hon. Senior Lecturer at Hull University Teaching Hospitals NHS Trust and Hull York Medical School. Dr Ahmed graduated from Dow Medical College Karachi, Pakistan in 1986.  He moved on to the UK after his residency and received his neurology training at St James’s University Hospital, Leeds and Imperial College London.  He did his research on cerebral blood flow in migraine and clinical training in headache at the Princess Margaret Migraine Clinic, Charing Cross Hospital, London.  He was appointed as Consultant Neurologist in Hull in 1996 where he established a dedicated headache clinic. He did his MBA in Public Sector Management from University of Hull in 2010 and a post-graduate certificate in medical education (PGCME) in 2015 and is currently the Educational Officer of the British Association for the Study of Headache having served as a Secretary (2005-2008), Vice Chair (2009-2010) and Chair (2011-2013). He is a Trustee of the International Headache Society and Migraine Trust, Chair of Anglo-Dutch Migraine Association (ADMA), member of Headache advisory group at the Association of British Neurologist and Director of Migraine Trust International Symposium (MTIS). He is a former Chair of Headache UK and Director of the European Headache and Migraine Trust International Congress (EHMTIC). He served on NICE in the development of Headache Guideline (CG150) and has co-authored the current BASH guidelines 2019.

    Disclosures
    Trustee of Migraine Trust, Migraine Trust International Symposium (MTIS), British Association for the Study of Headache (BASH) and Anglo Dutch Migraine Association (ADMA), Association of British Neurologists (ABN), North of England Neurological Association (NENA) and Dow Graduate Association of Northern Europe (Dogane). Received honoraria paid to charity from Allergan, Novartis, Teva, electroCore, and Eneura

  • Gianluca Coppola (Italy)
    Institution: Sapienza University of Rome
    Country: Italy

    Gianluca Coppola, MD, PhD, is board-certified neurologist since 2005 and holds doctoral degree from Sapienza University of Rome. He is clinical neurologist at Sapienza University of Rome Polo Pontino. He obtained the certification of Full Professor of Neurology. He is member of the International Headache Society, of the Italian Societies for the Study of Headache, of Clinical Neurophysiology, of Psychophysiology, of Neurology, and of Psychophysiology and Cognitive Neurosciences.

    Disclosure

    Secretary - Italian Society for the Study of Headaches (SISC)

  • Mario Peres (Brazil)
    Institution: Sao Paulo Headache Center
    Country: Brazil

    Mario F P Peres, MD, PhD, FACP, is the Founder of the São Paulo Headache Center and Program Director of the Headache Medicine training for the Neurology Residency Program at Albert Einstein Hospital in São Paulo, Brazil. Senior Researcher and Professor of Postgraduation at Albert Einstein Hospital and at Psychiatry Institute, São Paulo State University Medical School. Born in São Paulo in 1971, had neurology residency training in 1998, PhD in Neurology in 2000 at Federal University of São Paulo, Headache Fellowship at Jefferson Headache Center, Thomas Jefferson University in 2000-2001.
     
    Dr Peres has authored and/or co-authored more than 130 peer-reviewed publications, book chapters, and a book to headache patients. He has been dedicated the past 15 years full time to the headache field, in clinical practice, academic training, public awareness and research. Developed a headache medicine E-learning program for health professionals, a headache diary app, and internet content with more than 10 million individual page views in the past years.

    He has been served as member of several committees at the Internation Headache Society and Brazilian Headache Society, currently part of the Ethics Committee, Cluster Headache Study Group, and Headache Classification working group, and is a member of the IHS-GPAC Core Team.
     
    Disclosures
    Consulting / advisory board: Eli Lilly, Novartis, Eurofarma, Teva, Allergan

  • Patricia Pozo-Rosich (Spain)
    Institution: University Hospital Vall d Hebron
    Country: Spain

    Patricia Pozo-Rosich, MD PhD, is a specialist in neurology, and is currently in charge of the Headache and Neurological Pain Clinical Unit at the University Hospital Vall d’Hebron, Barcelona, Spain, and the Headache Research Laboratory at the Vall d’Hebron Institute of Research (VHIR), which is a part of the Autonomous University of Barcelona.

    After winning the La Caixa and AHS awards, she became a Fellow in Basic Research, first with Professor Stephen Silberstein at the Thomas Jefferson University, PA, US, and subsequently, collaborated with Professor Peter Goadsby on research projects at both the University College London, UK, and the University of California San Francisco, CA, US.

    Dr Pozo-Rosich’s research focuses on improving the quality of life of patients suffering from headache by increasing our understanding of headache pathophysiology. In her role as a member of the International Headache Genetics Consortium, she has been involved in numerous projects on the genetics of migraine. She has received funding from the Fondo de Investigaciones Sanitarias (ISCIII), the La Marató de TV3 Foundation, the Migraine Research Foundation and la Caixa Foundation, to develop translational research projects. Her clinical research experience includes participating as a principal investigator in phase II, III and IV trials.

    She has directed PhD students and teaches residents, students, neurologists and other physicians. She is a professor in the Translational Research Master at the VHIR.

    She is a member of the International Headache Society, where she is a member of the Clinical Trials Guidelines Committee and the IHS Women’s Leadership Forum. She is also a member of the American Headache Society. She is the past-president of the Headache Study Group of the Spanish Neurological Society (cefaleas.sen.es)

    She is the Editor for Headache in Revista de Neurologia, Associate Editor for Frontiers in Neurology – Headache Section- and the Journal of Headache and Pain. She has published  original and review papers, , book chapters, and edited several National Guidelines, authored a book and launched the website www.midolordecabeza.org for the Headache Spanish speaking community focused both on patients and physicians.
     
    Disclosures
    Consulting, Educational and Speaker fees: Allergan,Almirall, Chiesi, Eli Lilly, Novartis, Teva

     

  • Todd Schwedt (USA)
    Institution: Mayo Clinic
    Country: USA

    TTodd Schwedt, MD, MSCI is a Professor of Neurology and Chair of Neurology Research at the Mayo Clinic Arizona.  In addition to his clinical duties in the Mayo Headache Clinic, he leads an active headache research portfolio.  He is a principal investigator of the Neuroimaging of Headache Laboratory at Mayo Clinic, of the American Registry for Migraine Research (ARMR), the Medication Overuse Treatment Strategy Trial (MOTS), and he is the Medical Director of the Mayo Clinic Arizona Clinical Studies Unit. He was a recipient of the 2015 Harold G. Wolff Award from the American Headache Society, an award presented annually to a researcher who has most significantly contributed to the understanding of headache. Dr. Schwedt serves on the Executive Committee for the Board of Directors for the American Headache Society, is Co-Chair for the 2021 International Headache Congress, is a member of the American Headache Society scientific meeting planning committee, is the chairperson of the post-traumatic headache working group for the International Classification of Headache Disorders, and is an associate editor for Cephalalgia, Headache, and Headache Currents. Dr. Schwedt is a frequent lecturer and has authored over 115 peer-reviewed publications.

    Disclosures

    Research Funding: National Institutes of Health (NIH); United States Department of Defense (DOD); Mayo Clinic / Arizona State University; American Migraine Foundation; Patient Centered Outcomes Research Institute (PCORI), Amgen
    Consulting: Alder, Allergan; Amgen; Avanir; Biohaven, Dr. Reddy’s, Eli Lilly, Equinox, Ipsen Bioscience, Novartis; Teva, XoC Pharmaceuticals
    Options: Aural Analytics, Nocira, Second Opinion

  • Alexandra Sinclair (UK)
    Institution: University of Birmingham
    Country: UK

    Professor Alexandra Sinclair MBChB (Hons) MRCP, PhD graduated from the University of Birmingham School of Medicine in 2000 and attained her MRCP in 2003. She then trained as a Neurology Specialist Registrar in the West Midlands before taking time out of her training to pursue research interests as a Medical Research Council, Clinical Research Training Fellow at the University of Birmingham.

    She attained her PhD in 2010 along with a number of prizes for her research: Steven Whittaker Prize, West Midlands Physicians Association (November 2009), Pushpa Chopra Prize, runner-up, Medical Research Society, UK (February 2009), Individual Speciality Award, Medical Research Society, UK (February 2008), Michael Jefferson Prize, Midlands Neurology Society (November 2007) and a poster prize, Society for Endocrinology (March 2007).

    Professor Sinclair now works as a Clinician Scientist with a role combining clinical neurology with translational research into idiopathic intracranial hypertension and the neuroendocrine aspects of headache.

    Professor Sinclair and her research group recently hosted a high profile visit from NASA. NASA are interested in Professor Sinclair's expertise on raised Intracranial pressure stemming from her leading Idiopathic Intracranial Hypertension clinical service at University Hospital Birmingham coupled with her translational science portfolio at the University of Birmingham. Her recent discovery of the novel use of Glucogon-like peptide 1 receptor agonists to reduce intracranial pressure are of particular interest to the NASA team in their quest to reduce brain pressure during long duration space travel and allow them to go beyond the Moon.


Ex-officio Trustee:
 
  • Arne May (Germany)
    Institution: Universitäts-Krankenhaus Eppendorf (UKE)
    Country: Germany

    Arne May is a Professor of Neurology in the Department of Systems Neuroscience at the University of Hamburg and head of the headache outpatient clinic and the facial outpatient clinic of the University clinic of Hamburg. His major research interests are the basic mechanisms of facial and headpain, the chronification of pain and plasticity within the human brain. The work of his group involves human imaging studies in primary headache as well as experimental studies of trigeminovascular nociception, with the aim of understanding how to modulate facial and headache syndromes and chronicity of pain. Prior to his position at the University of Hamburg, Professor May was a clinician and conducted research into pain and headache syndromes at the University of Regensburg. Prior to this he completed his residency in the Neurology Department of the University of Essen, followed by post-doctorate studies at the Institute of Neurology in London. Professor May is currently a member of the Board of trustees of the International Headache Society since 2013. He has published around 300 original and review articles with an h-index of 66 and is since 2016 the Editor of Cephalalgia.

    Disclosures
    None

  • Allan Purdy (Canada)
    Institution: Dalhousie University
    Country: Canada

    R. Allan Purdy MD, FRCPC, is Professor of Medicine (Neurology) at Dalhousie University. He was Professor and Head of the Department of Medicine, and Chief of the Medicine Service of the Department of Medicine at Dalhousie and Capital Health from 2005 to June of 2011. He is a Fellow of the Royal College of Physicians of Canada, and was elected a Fellow of the American College of Physicians in 2008. He previously was the Professor and Head of Neurology at Dalhousie from 1994 to 2006. He is a Fellow of the American Headache Society and is the current Past-President of the American Headache Society. 

    Dr. Purdy is Past - President of the Canadian Headache Society. He is the Chair of the Education Committee of the International Headache Society and is on the Board of Directors of the both Societies. He directs headache educational courses worldwide, and has received Excellence in Teaching Awards on many occasions. He has been involved in guideline develop for the treatment of migraine and has been involved in clinical research in migraine and has several publications.

    He is co-editor of Advanced Therapy of Headache and co-author of Headache Pocket Clinician 2010 from Cambridge University Press. In 2005 he received the Arnold P. Friedman Distinguished Clinician Research Award from the American Headache Society for outstanding contribution to the field of headache, and the 2007 Life Time Achievement Award from the Headache Cooperative of New England. He has been on the Editorial Board of Cephalalgia and is currently an Associate Editor for Headache. He is the 2018 recipient of the John R. Graham Lecture Award from the American Headache Society for international leadership in research and education in the field of headache. In 2019 he received the John Edmeads Award from the Canadian Headache Society for his work in the field of headache and resident education in Canada.

    Disclosures
    None.


Co-opted Trustees:
 
  • Mi Ji Lee (S Korea)
    Institution: Samsung Medical Center, Sungkyunkwan University School of Medicine
    Country: S Korea

    Mi Ji (Miji) Lee, MD, PhD is a Clinical Assistant Professor of Neurology at the Sungkyunkwan University in Korea. She has been working as a headache specialist in the Neurology department of Samsung Medical Center and actively performing research on headache disorders.

    Dr. Lee obtained her MD, summa sum laude, at the Sungkyunkwan University. She completed the Neurology residency and 3-year fellowship in the field of stroke and headache in Samsung Medical Center.
    She is an associate academic director of Korean Headache Society. She has served as a Juniors Group member of International Headache Society.

    She received several research awards and grants. She received Hyangseol young investigator award for the distinguished research performance in neurology and LG future medical investigator award for having highest research performance in the whole medical field in Korea. She has been selected as a rising researcher by the Korean Academy of Science and Technology, which nominates investigators having outstanding research performance in the whole science field. She got research grants from the National Research Foundation (NRF) of Korea and the Korean Society of Neurosonology.

    She authored more than 100 papers, abstracts, and book chapters on the topic of headache and stroke. Her research interests include migraine, cluster headache, RCVS, pressure-related headache, and other primary and secondary headaches. In addition to several investigator-initiated studies completed or ongoing, she acted as a site PI of phase III trials of anti-CGRP monoclonal antibodies. She is working on several international collaborative projects on migraine, cluster headache, and RCVS.

    Disclosures
    Speaker fees: Sanofi-Aventis, YuYu Pharma. Research support: Yuhan Company

  • Marco Lisicki (Argentina)
    Institution: Conci . Carpinella Institute
    Country: Argentina

    Marco Lisicki MD, PhD, MHD, is a Latin American Headache Neurologist. He coordinates the multidisciplinary headache and neuropathic pain clinical and research team of the Neuroscience Unit at Conci∙Carpinella Institute in Córdoba, Argentina. He obtained his Medicine and Neurology Specialist Degrees in Córdoba, and holds a Master of Headache Disorders Diploma from the University of Copenhagen and a PhD from the University of Liège. He is a former member of the IHS Trainees and Residents Special Interest Group. His research interests include headache pathophysiology, treatment, and burden. He is actively involved in the development of local patients associations, as well as in other activities that aim to increase headache awareness in the region.

    Disclosures
    Honoraria and travel grants from Novartis. Travel grants from Allergan. Research support to laboratory (2015-2018) from Cefaly Technology, Electrocore, Amgen, Novartis, Teva, Eli Lilly and Co. 

  • Aynur Ozge (Turkey)
    Institution: Mersin University School of Medicine
    Country: Turkey

    Professor of Neurology, Algology and Clinical Neurophysiology in Mersin University School of Medicine in Turkey, an international lecturer, writer, and the founder and active chairwoman of the board for the Turkish Alzheimer’s Association Mersin Branch. She founded the first and unique Dementia-Alzheimer Elderly Care Center in the country which specializes in a unique 5-step comprehensive care model for coping with Alzheimer’s Disease.

    Disclosures
    None

     

  • Kirill Skorobogatykh (Russian Federation)
    Institution: University Headache Clinic Moscow
    Country: Russian Federation

    Dr Kirill Skorobogatykh MD, PhD is neurologist, headache specialist, head of University Headache Clinic (Moscow, Russia).

    He completed neurology residency training in 2005, PhD in neurology in 2008 in Sechenov University (Moscow), had clinical observership at Jefferson Headache Center, Thomas Jefferson University in 2010.

    In 2012 Dr Skorobogatykh founded the University Headache Clinic in Moscow, which is now center for clinical work, research and education for headache specialists. Dr Skorobogatykh research focuses on epidemiology, comorbidity and genetics of migraine. He participated as PI or SI in phase III and IV clinical trials. He is representative of Russia to the European Headache Federation and a member of the International Headache Federation.

    Dr Skorobogatykh is a frequent lecturer on headache and pain disorders for residents, neurologists and other physicians. Since 2013 co-organises Russian Headache Congress (approx. 400 attendees each year) which was supported by IHS (in 2017) and by EHF (in 2018 and 2019). He is co-orginizer of the EHF Headache schools in Moscow. He has special commitment for raising the awareness of migraine in media.

    Dr Skorobogatykh has particular interest not only in clinical work and education, but also in the development of tools that help patients and doctors to interact, for example, developed chat-based headache diary Migrebot.


    Disclosures
    Fees for lecturing and participation in advisory boards from Novartis and Teva.
    Primary investigator or SI for clinical trials sponsored by Allergan, Novartis, Teva, Alder and Eli Lilly.


 

STANDING COMMITTEE CHAIRS
Cephalalgia:

 
  • Arne May (Germany)
    Institution: Universitäts-Krankenhaus Eppendorf (UKE)
    Country: Germany

    Arne May is a Professor of Neurology in the Department of Systems Neuroscience at the University of Hamburg and head of the headache outpatient clinic and the facial outpatient clinic of the University clinic of Hamburg. His major research interests are the basic mechanisms of facial and headpain, the chronification of pain and plasticity within the human brain. The work of his group involves human imaging studies in primary headache as well as experimental studies of trigeminovascular nociception, with the aim of understanding how to modulate facial and headache syndromes and chronicity of pain. Prior to his position at the University of Hamburg, Professor May was a clinician and conducted research into pain and headache syndromes at the University of Regensburg. Prior to this he completed his residency in the Neurology Department of the University of Essen, followed by post-doctorate studies at the Institute of Neurology in London. Professor May is currently a member of the Board of trustees of the International Headache Society since 2013. He has published around 300 original and review articles with an h-index of 66 and is since 2016 the Editor of Cephalalgia.

    Disclosures
    None


Child & Adolescent:
 
  • Ishaq Abu-arafeh (UK)
    Institution: Royal Hospital for Children
    Country: UK

    Ishaq Abu-Arafeh was born in Jerusalem and qualified in Medicine (MBBS) from the University of Jordan in Amman, Jordan. He started his paediatric career in Bethlehem after junior internship in Jerusalem, Palestine. He moved to the UK and took higher specialist training in general paediatrics, neonatal intensive care and paediatric Neurology in Leeds, Cardiff, Sheffield and Aberdeen. As a research fellow to Professor George Russell, between 1991 and 1993, he established interest in headache and studied the epidemiology of headache and the periodic syndrome in Aberdeen schoolchildren, which was the subject of his postgraduate thesis for his MD from the University of Aberdeen.

    Dr Abu-Arafeh is a Fellow, a Trustee and a Council member of the Royal College of Paediatrics and Child Health. He is also a Council member of the British Paediatric Neurology Association. He is a co-founder of the Scottish Paediatric Neurology Group and he was the honorary secretary of the Scottish Paediatric Society (2003-11).

    He took the post of a consultant in paediatrics and paediatric neurology at Forth Valley Royal Hospital and The Royal Hospital for Sick children in Glasgow, UK, in 1995 and continued his clinical and research interest in children's headache. He established the Headache Clinic at the Royal Hospital for Sick Children in Glasgow and it became one of the largest, if not the largest, headache service for children in the UK.

    Dr Abu-Arafeh contributed to patient support groups as a medical advisor for Cyclical Vomiting Syndrome Association- UK and the Migraine Action Association. He is a member of the British Association for the Study of Headache and was chairperson of its paediatric committee between 2007 and 2011. He has been a member of the International Headache Society for the past 20 years and presented his work at several IHS congresses, starting with wining the prize for the best poster presentation in 1993 in Paris. He contributed to the International Classification of Headache Disorders II and III and gave invited lectures at several IHCs, Migraine Trust and EHMTIC Symposia.

    Ishaq Abu-Arafeh plays an important role in raising awareness of childhood headache and medical education. He organised three Childhood Headache Symposia in the UK (London 2002 and 2006 and Glasgow 2008). He also took part in the development of the British Paediatric Neurology Association's Children Headache Teaching Course (CHaT -1), which has now become a well established course and has been run across many centres in the UK. He is the editor of 'Childhood Headache' which is now in its second edition.

    On taking the chairmanship of the Child and Adolescent Standing Committee, Dr Abu-Arafeh aims to reach out to all IHS members working with children in order to be inclusive and raise the profile of issues related to childhood headache within the IHS and beyond.

    Disclosures
    Honoraria received from RB Pharmaceuticals for developing educational material, as Podcast and webinars
     


Classification:
 
  • Peter J Goadsby (UK)
    Institution: NIHR-Wellcome Trust Clinical Research Facility, King's College Hospital
    Country: UK

    Peter Goadsby obtained his medical degree and training at the University of New South Wales (UNSW), Australia. Neurology training was with James W. Lance and clinical neurophysiology with David Burke. After post-doctoral work in New York with Don Reis at Cornell, Jacques Seylaz at Universite VII, Paris, and post-graduate neurology training at Queen Square, London with C David Marsden, Andrew Lees, Anita Harding and W Ian McDonald, he returned to UNSW, and the Prince of Wales Hospital, Sydney as a consultant neurologist and became an Associate Professor of Neurology. He was appointed a Wellcome Senior Research Fellow at the Institute of Neurology, University College London in 1995. He was Professor of Clinical Neurology and Honorary Consultant Neurologist at the National Hospital for Neurology and Neurosurgery, Queen Square, London until 2007.

    He has been Professor of Neurology, Department of Neurology, University of California, San Francisco since 2007. He has been an Honorary Consultant Neurologist at the Hospital for Sick Children, Great Ormond St, London since 1998.

    In 2013 he was appointed Director, NIHR-Wellcome Trust King’s Clinical Research Facility, King’s College Hospital, Professor of Neurology at King’s College London and Honorary Consultant Neurologist, King’s College Hospital.

    His major research interests are in the basic mechanisms of primary headache disorders, such as migraine and cluster headache, in both experimental and clinical settings, and translating these insights into better management. 

    Disclosures
    Dr Goadsby reports personal fees from Alder Biopharmaceuticals, personal fees from Allergan, grants and personal fees from Amgen, personal fees from Autonomic Technologies Inc., personal fees from Biohaven Pharmaceuticals Inc., grants and personal fees from Eli Lilly and Company, personal fees from Electrocore LLC, personal fees from eNeura Inc, personal fees from Impel Neuropharma, personal fees from MundiPharma, personal fees from Novartis, personal fees from Teva Pharmaceuticals, other from Trigemina, personal fees from WL Gore, personal fees from Gerson Lehrman Group, personal fees from Guidepoint,  outside the submitted work;  In addition, Dr Goadsby has a patent Magnetic stimulation for headache licensed to eNeura without fee and Fees for publishing from Oxford University Press, Massachusetts Medical Society, Wolters Kluwer and for medicolegal work.


Clinical Trials:
 
  • Gisela M Terwindt (Netherlands)
    Institution: Leiden University Medical Centre
    Country: Netherlands

    Gisela Terwindt received her MSc in Biology and MD in Medicine at the University of Leiden, the Netherlands. Her PhD encompassed epidemiology and genetics of migraine, with the discovery of the first migraine gene. She is associate professor of Neurology, and Consultant Neurologist, at the Department of Neurology, Leiden University Medical Center (LUMC), Netherlands, where she also runs the Headache Clinic.

    Gisela Terwindt is chair of the scientific committee of the Dutch Headache Society. She is member of the International Headache Classification Committee, the IHS Ethics Committee, and chair of the IHS Women’s Leadership Forum.

    She has published >150 scientific papers and several book chapters on headache and migraine.  She received a prestigious personal grant from the Dutch Organisation of Scientific Research (VIDI-award).

    Disclosures

    Gisela Terwindt reports  independent support from NWO, European Community, and the Dutch Heart Foundation.


Education:
 
  • Allan Purdy (Canada)
    Institution: Dalhousie University
    Country: Canada

    R. Allan Purdy MD, FRCPC, is Professor of Medicine (Neurology) at Dalhousie University. He was Professor and Head of the Department of Medicine, and Chief of the Medicine Service of the Department of Medicine at Dalhousie and Capital Health from 2005 to June of 2011. He is a Fellow of the Royal College of Physicians of Canada, and was elected a Fellow of the American College of Physicians in 2008. He previously was the Professor and Head of Neurology at Dalhousie from 1994 to 2006. He is a Fellow of the American Headache Society and is the current Past-President of the American Headache Society. 

    Dr. Purdy is Past - President of the Canadian Headache Society. He is the Chair of the Education Committee of the International Headache Society and is on the Board of Directors of the both Societies. He directs headache educational courses worldwide, and has received Excellence in Teaching Awards on many occasions. He has been involved in guideline develop for the treatment of migraine and has been involved in clinical research in migraine and has several publications.

    He is co-editor of Advanced Therapy of Headache and co-author of Headache Pocket Clinician 2010 from Cambridge University Press. In 2005 he received the Arnold P. Friedman Distinguished Clinician Research Award from the American Headache Society for outstanding contribution to the field of headache, and the 2007 Life Time Achievement Award from the Headache Cooperative of New England. He has been on the Editorial Board of Cephalalgia and is currently an Associate Editor for Headache. He is the 2018 recipient of the John R. Graham Lecture Award from the American Headache Society for international leadership in research and education in the field of headache. In 2019 he received the John Edmeads Award from the Canadian Headache Society for his work in the field of headache and resident education in Canada.

    Disclosures
    None.

  • Henrik Winther Schytz (Denmark)
    Institution: Danish Headache Center
    Country: Denmark

    Henrik Schytz is a consultant in neurology and associate professor at the Danish Headache Center at the Department of Neurology, Rigshospitalet Glostrup, University of Copenhagen.

    Henrik graduated as a MD in 2004 at the University in Copenhagen, from where he also received his PhD in 2010 and doctoral degree in medical science in 2015. He is the recipient of the Harold Wolff-John Graham Award for Headache/Facial Pain Research and the 2014 G. Nappi Cluster Headache Award. Henrik is the current president of the Danish Headache Society from where he has been a board member since 2001.

    In 2016, Henrik started the international Master in Headache Disorders at the University of Copenhagen in collaboration with Professor Rigmor Jensen, which is a successful running continuing professional development program for healthcare professionals.

    Henrik Schytz has been actively involved in headache research since 2005 and has authored more than 70 articles and book chapters in the headache field. His main interests include diagnostic testing of headache, human headache models, neuroimaging as well as treatment of migraine and secondary headaches. Henrik is currently head of the Headache Diagnostic Laboratory at the Danish Headache Center.

    Disclosures
    Honoraria for lecturing from Novartis, and Teva. Honoraria for serving on the scientific advisory board of Lilly and BalancAir. Received grant from Novartis.


Electronic Media:
 
  • Anna Andreou (UK)
    Institution: Headache Research, Section of Anaesthetics, Pain Medicine and Intensive Care - Faculty of Medicine, Imperial College London
    Country: UK

    Anna Andreou completed her PhD in Neurology at the Institute of Neurology-Queen Square, where she investigated the therapeutic potentials of novel glutamate channels in migraine treatment. She then moved to the University of California San Francisco, where she focused her research on the investigation of brain networks involved in migraine pathophysiology and the effectiveness of neurostimulation in headaches. Anna is now a headache research fellow at Imperial College London, funded by The Migraine Trust Fellowship.

    Since the completion of her PhD, Anna has received a number of awards including the Thomas E. Heftler Migraine Research Award by the American Headache Society and the Migraine Research Foundation, and the 2012 Early Research Career Grant by the International Association for the Study of Pain. She is also a co-recipient of the Enrico Greppi Award in 2010, and she received twice the EHMTIC New Scientist Lecture and the AHS Frontiers in Headache Research Scholarship Awards .

    Anna is a member of the IHS since 2005, and is past Chair of the Trainees and Residents SIG.

    Disclosures
    Honoraria received from: eNeura; Allergan

  • Arao Belitardo De Oliveira (Brazil)
    Country: Brazil

    Disclosures

    None


Ethics:
 
  • Morris Levin (USA)
    Institution: UCSF Headache Center
    Country: USA

    Dr Levin is Professor of Neurology at the University of California, San Francisco, where he directs the UCSF Headache Center and the Headache Medicine Fellowship.   He is actively involved in research and teaching activities at UCSF. 

    Prior to joining the UCSF Department of Neurology in 2014, Dr Levin was a long-time faculty member at Dartmouth Medical School and co-directed the Dartmouth Headache Center with his colleague Dr Thomas Ward. He was also the Neurology clerkship director there and Neurology residency Program Director for many years.  From 2011 to 2014 he served as Chair of the School of Medicine Faculty Council (faculty senate). 

    Dr Levin earned his undergraduate degree in Biological Sciences at Stanford University, and his MD degree at the Chicago Medical School. His neurology residency training was at the Albert Einstein College of Medicine in New York.  His training in Headache Medicine and Pain medicine took place at the Montefiore Headache Unit in New York, and the Michigan Head-Pain and Neurological Institute in Ann Arbor, Michigan. He is board certified in Neurology with special qualification in Pain Medicine (ABPN) and is board certified in Headache Medicine (UCNS) as well.

    Dr Levin authored a number of medical journal articles and textbook chapters in the areas of headache and pain.  He is the author of Neurology Clinical Case Studies (Anadem 2003), Comprehensive Review of Headache Medicine (Oxford University Press 2008) and Emergency Neurology (Oxford University Press 2013). He is the co-author of Head, Neck and Facial Pain (Anadem 2006), Educational Review Manual in Neurology (Castle Connolly 2006), Headache and Facial Pain (Oxford University Press 2009) and Refractory Migraine (Oxford University Press 2010). He is also the co-author of “Understanding Your Migraines” (Oxford University Press 2017), written primarily for patients and families.

    He is an active member of the American Headache Society, International Headache Society, Headache Cooperative of New England, Headache Cooperative of the Pacific, American Neurological Association, and American Academy of Neurology.  He is a Fellow of the AAN, AHS and ANA. He is the chair of the International Headache Society’s Ethics Committee and is a member of the IHS Classification Committee.

    Disclosures
    Occasional consulting/advising: Allergan, Amgen, Supernus, Pernix, Lilly


Leadership & Development:
 
  • Lars Edvinsson (Sweden)
    Institution: University Hospital of Lund
    Country: Sweden

    Lars Edvinsson is currently Professor and senior consultant at Lund University/Hospital in Internal Medicine, MD PhD, and Chairman of the Swedish Migraine Society, on the board of EHF, immediate past president of IHS.

    In 2008 Lars Edvinsson was called to be professor at the Copenhagen University in "Receptor Regulation in Cerebrovascular and Cardiovascular Diseases" and in 2007 funded and is currently Director of the Glostrup Research Park, Copenhagen. In 2012 he received a Lifetime Achievement award from American Headache colleagues (Stowe, VT), and Honoray Dr Hon Causa in Szeged, Hungary.

    He has a long history in studies of the cerebral circulation, innervation, receptors and function. In 1984 He was the first to describe CGRP in cranial vessels and the trigeminal ganglion, showed the release of CGRP in conjunction with migraine and cluster headache attacks, and has been instrumental in the development of novel CGRP receptor antagonists. His current work is centered at finding lokalisation of CGRP family of receptors in cranial structures and in CNS in order to illustrate the possible sites of action of novel CGRP acting drugs. The work involves also studies of other possible migraine candidates such as PACAP and 5-HT subtype receptor expressions as well as studies of their interactions and functional roles.

    Disclosures
    Supported by companies for talks at different symposia and locally


Membership:
 

Science & Research:
 
  • Hans-Christoph Diener (Germany)
    Country: Germany

    Hans-Christoph Diener, MD, PhD is affiliated with the Institute for Epidemiology at the University Duisburg-Essen. He was Professor of Clinical Neurosciences at the Medical Faculty of the University Duisburg-Essen from 2016-2019. He was Professor of Neurology, Chairman of the Department of Neurology and Director of the Essen Headache Centre at the University of Duisburg-Essen in Germany from 1989 to 2016. He was President of the German Neurological Society, President of the European Headache Federation (EHF), and the International Headache Society and chaired the German Headache Consortium

    Professor Diener received his medical degree and doctorate at the Albrecht-Ludwigs-Universität in Freiburg, and continued his training there in the Departments of Neurology, Psychiatry, Internal Medicine and Surgery. Prior to joining the University of Essen in 1989, he was an Associate Professor of Neurology at the Department of Neurology at the University of Tübingen. He was a visiting Professor at the Neurological Sciences Institute in Portland, Oregon in 1984 and 1985 and at the University of New South Wales in Sydney in 1987 and 1988.

    Professor Diener has been the PI in more than 30 trials on the acute treatment and prophylaxis of headache disorders.

    Professor Diener has authored or co-authored 962 articles in peer reviewed journals (192 as first author, 21 in the NEJM), 352 invited reviews, and 367 book chapters, and served as the editor or author of 84 books. His h index is 120. He is the editor of Neurology Up2date, Arzneimitteltherapie, Info Neurologie & Psychiatrie, deputy editor of Cephalalgia, Stroke Editor for Current Neurology and Neurosciences Reviews and serves on the editorial boards of Lancet Neurology and Cerebrovascular Diseases.

    Disclosures
    In the last 3 years HCD received honoraria for participation in clinical trials, contribution to advisory boards or oral presentations from: Allergan, Amgen, Electrocore, Lilly, Novartis, Teva,Weber & Weber and WebMD. HCD has no ownership interest and does not own stocks of any pharmaceutical company. HCD serves on the editorial boards of Cephalalgia and Lancet Neurology. HCD chairs the Clinical Guidelines Committee of the German Society of Neurology and is a member of the Clinical Trials Guideline Committee of the IHS.

  • Shuu Jiun Wang (Taiwan)
    Institution: The Neurological Institute, Taipei Veterans General Hospital
    Country: Taiwan

    Dr. Shuu-Jiun Wang is a practicing neurologist and the Chair Professor and Director, Brain Research Center, National Yang-Ming University School and Director of The Neurological Institute, Taipei Veterans General Hospital. Currently he is the Chair of the Asian Regional Consortium of Headache. He was the President of Taiwan Neurological Society from 2017 to 2019 and the founding President of the Taiwan Headache Society from 2005-2011. He serves as an associate editor of the journals Cephalalgia, Headache, and Journal of Headache and Pain and others. Dr. Wang was awarded the Bruce S. Schoenberg's International Neuroepidemiology Award by the American Academy of Neurology in Washington DC in 1994, the Seymour Solomon Lecture Award by the American Headache Society in LA in 2010 and the G. Nappi Cluster Headache Award by the European Headache Society, 5th European Headache and Migraine Trust International Congress (EHMTIC) in Glasgow, UK in 2016. He was also awarded Outstanding Research Award by the Ministry of Science and Technology, Taiwan in 2012 and 2018. Dr. Wang has authored more than 400 scientific papers. He enjoys teaching students and was awarded 2011 Outstanding in Teaching by National Yang-Ming University and 2018 Medical Education Contribution Award by Taipei Veterans General Hospital. He is interested in clinical and neuroimaging research of different headache disorders focusing on chronic migraine, cluster headache, reversible cerebral vasoconstriction syndromes and spontaneous intracranial hypotension.

    Disclosures
    Advisory board: Eli Lilly, Daiichi-Sankyo, Taiwan Pfizer; Honoraria: Taiwan branches of Allergan, Pfizer, Eli Lilly, Eisai, Bayer

SPECIAL INTEREST GROUP CHAIRS
Cluster Headache:

 
  • Jose Maria Pereira Monteiro (Portugal)
    Institution: Hospital Santo Antonio
    Country: Portugal

    José Maria Pereira Monteiro, MD, PhD, is Aggregated Professor of Neurology of the Instituto de Ciências Biomédicas Abel Salazar of the University of Porto, Consultant of Neurology, Founder and Chairman of the Outpatient Headache Clinic and the Headache Research Center (Centro de Estudos de Cefaleias) and Past Manager of the Outpatient Neurologic Clinic of the Department of Neurology of the Hospital Santo António, Porto, Portugal. His main interest is on the research of epidemiology and social impact of headaches, quality of life of headache patients, on headaches associated with vascular lesions, cervicogenic headaches, chronic daily headaches, neurophysiology of pain and autonomic nervous system, and treatment (drug trials) of migraine, but for the last two decades, mainly on genetics of migraine. He has several publications in international (75) and national (161) scientific journals and books (11) and book chapters (14) and over 500 communications in international (193) and national meetings (352).

    Dr Pereira Monteiro is Past-Member of the International Board of Functional Neurology and Co-Editor of a supplement of Functional Neurology on The Acute treatment of Migraine Attack, Editor of a Portuguese book on headache, "As Cefaleias na Clínica Geral" 1st and 2nd edition. He is Founder Member of the Portuguese Headache Society and of the European Headache Federation (EHF), and a Past-Member of the Executive Committee, Public Relations, Research Committees and of the Cluster Club of the EHF and of the Ethics Committee and Public Relations Committee. He was also Founder and first President of the IHS Portuguese Linguistic Committee and past representative of the Portuguese Headache Society to IHS and the European Headache Federation. He is also a past member of the Cervicogenic Headache International Study Group, Task Force on Chronic Daily Headache and Serotonin Club, Past-President of the Portuguese Neurological Society, Past delegate of the Portuguese Neurological Society at the European Federation of Neurological Societies and World Federation of Neurology, and Past President of the Sociedade Portuguesa de Cefaleias. Dr Pereira Monteiro is an Effective Member of the Sociedade Portuguesa de Neurologia, Sociedade Portuguesa de Cefaleias,  American Academy of Neurology (AAN), World Federation of Neurology (WFN), Member of the Research Groups on epidemiology, infectious diseases and headaches of the AAN and on Autonomic Disorders and Headaches of the WFN.

    Disclosures
    None


Emerging therapies:
 
  • Tim Juergens (Germany)
    Institution: University Medical Centre Rostock
    Country: Germany

    After his medical studies at the University of Düsseldorf, Tim Juergens specialised in clinical neurology at the Dept. of Neurology, University of Regensburg. He then joined Prof. Arne May's group at the University Medical Center Hamburg-Eppendorf where he obtained his Habilitation and became a board-certified pain specialist. At present, he is consultant at the Dept. of Neurology, University Medical Center Rostock, Germany (Director: Prof. Dr. Alexander Storch) and head of the Headache Center North-East. Additionally, he is vice-president of the German Migraine and Headache Society, Visiting Editor at The Journal of Headache and Pain and Associate Editor at Frontiers of Neurology (Section Headache Medicine and Facial Pain). His research interests cover neurophysiology and pain, neuromodulation in headache and pain, trigeminal autonomic cephalgias, human models of pain and facial pain.

    Disclosures
    Remuneration, honoraria, research support: Allergan; Autonomic Technologies, Desitin, Hormosan Pharma, MSD Germany, Pfizer
     


Juniors Group:
 
  • Anders Hougaard (Denmark)
    Institution: Danish Headache Centre
    Country: Denmark

    Anders Hougaard, MD, PhD, is a medical doctor and post-doctoral researcher at the Danish Headache Center, Department of Neurology, Copenhagen University Hospital, Denmark.
    Anders has been active in clinical headache research since 2009 and completed his PhD in Neuroscience on the topic of advanced magnetic resonance imaging investigations in migraine with aura in 2014 under the supervision of professors Messoud Ashina and Jes Olesen.
    His current main research interests include the pathophysiology of migraine (in particular migraine aura), neuroimaging methods in headache (MRI, fMRI, SPECT, PET), and headache trigger factors.
    Anders has currently authored and/or co-authored 52 peer-reviewed publications and co-authored 2 books on headache topics. H-index 19. While continuing his career in clinical neurology, headache medicine, and headache research, Anders is a lecturer on headache pathophysiology in the Master of Headache Disorders programme at the University of Copenhagen.

    Disclosures
    Honoraria for lecturing from Allergan, Novartis, and Teva. Honoraria for serving on the scientific advisory board of BalancAir.


Linguistic (Asian Regional Consortium of Headache):
 
  • Shuu Jiun Wang (Taiwan)
    Institution: The Neurological Institute, Taipei Veterans General Hospital
    Country: Taiwan

    Dr. Shuu-Jiun Wang is a practicing neurologist and the Chair Professor and Director, Brain Research Center, National Yang-Ming University School and Director of The Neurological Institute, Taipei Veterans General Hospital. Currently he is the Chair of the Asian Regional Consortium of Headache. He was the President of Taiwan Neurological Society from 2017 to 2019 and the founding President of the Taiwan Headache Society from 2005-2011. He serves as an associate editor of the journals Cephalalgia, Headache, and Journal of Headache and Pain and others. Dr. Wang was awarded the Bruce S. Schoenberg's International Neuroepidemiology Award by the American Academy of Neurology in Washington DC in 1994, the Seymour Solomon Lecture Award by the American Headache Society in LA in 2010 and the G. Nappi Cluster Headache Award by the European Headache Society, 5th European Headache and Migraine Trust International Congress (EHMTIC) in Glasgow, UK in 2016. He was also awarded Outstanding Research Award by the Ministry of Science and Technology, Taiwan in 2012 and 2018. Dr. Wang has authored more than 400 scientific papers. He enjoys teaching students and was awarded 2011 Outstanding in Teaching by National Yang-Ming University and 2018 Medical Education Contribution Award by Taipei Veterans General Hospital. He is interested in clinical and neuroimaging research of different headache disorders focusing on chronic migraine, cluster headache, reversible cerebral vasoconstriction syndromes and spontaneous intracranial hypotension.

    Disclosures
    Advisory board: Eli Lilly, Daiichi-Sankyo, Taiwan Pfizer; Honoraria: Taiwan branches of Allergan, Pfizer, Eli Lilly, Eisai, Bayer


Linguistic (French):
 
  • Michel Lanteri-Minet (France)
    Institution: Chu Nice, Hôpital Cimiez
    Country: France

    Disclosures

    In the last five years, I have received honoraria in clinical trials, contribution to advisory boards, or oral presentations from Allergan, Amgen, Astellas, ATI, BMS, Boehringer, Boston Scientific, CoLucid, Convergence, Glaxo-SmithKline, Grunenthal, Lilly, Medtronic, Menarini, MSD, Novartis, Pfizer, ReckittBenckiser, Saint-Jude, Sanofi-Aventis, UCB, Zambon.

     


Linguistic (Hispanic):
Linguistic (Italian):
 
  • Vincenzo Guidetti (Italy)
    Country: Italy

    Since 2001, Vincenzo Guidetti has been Professor of Child and Adolescent Neurology and Psychiatry at the University of Rome “La Sapienza”. He is also the Director of the Child and Adolescent Headache Center of the Department of Child and Adolescent Neurology and Psychiatry (University of Rome “La Sapienza”).

    Vincenzo Guidetti has been a member of IHS (Munich 1983). He was Chairman of the Paediatric Subcommittee from 1995-2003, a member of the Executive Committee from 2003-2009, and originator  of the International Headache Society Master Schools.

    He was President of the Italian Headache Society from 2009-2010, Chairman of  the Executive of Child and Adolescent Neuropsychiatry University Professors 2011-2017, Member of the Executive of Italian Medical Professor Association 2011-2018 and Director of Postgraduate School in Child and Adolescent Neuropsychiatry from 2013 to present.

    Disclosures

    Amgen Advisory Board; Xenon Pharmaceutical, Consultant


Linguistic (Portuguese):
 
  • Isabel Maria dos Santos Luzeiro (Portugal)
    Institution: Coimbra's Hospitalary and University Center
    Country: Portugal

    Isabel Luzeiro gained her medical degree in 1984 from the University of Coimbra, Portugal. She did her Neurology specialisation at Coimbra's Hospitalary and University Center (CHUC) and further training in Neurophysiology at Saint Vincent Paul's Hospital in Paris, France. She has an MSc in Pain Sciences from the University of Lisbon and a European Examination Certificate in Sleep Medicine (2015, Barcelona, Spain).. Dr Luzeiro is currently Graduated Assistant of Neurology and Neurophysiology at the CHUC. She is a past President of the Portuguese Headache Society and currently a member of the Scientific Committee of the Portuguese Headache Society and the International Delegate in the European Headache Federation for Portuguese-speaking countries.

    Disclosures
    None


Linguistic (Russian):
 
  • Zaza Katsarava (Germany)
    Institution: Evangelical Hospital, Unna, and University of Essen
    Country: Germany

    Zaza Katsarava, MD, PhD, MSc, is a head of the department of neurology at the evangelic hospital in Unna and a Professor of Neurology at the University of Essen in Germany. He is President of the European Headache Federation, Chair of the Russian Linguistic Subcommitte of the International Headache Society and Co-chair of the Georgian National Headache Association.

    Dr Katsarava graduated from Medical University in Tbilisi, received training in neurology at the Medical Academy in Tbilisi and accomplished his PhD in the Institute of Physiology in Tbilisi in the Republic of Georgia. He trained further in neurology and psychiatry at the University of Essen in Germany, obtained degree of Master of Science in Clinical Epidemiology at the Harvard School of Public Health in Boston and a certificate in quality assurance in medicine at the Johns Bloomberg Hopkins School of Public Health in Baltimore, USA.
    Dr Katsarava's main interest focuses on headache and pain, especially the risk factors and mechanisms of chronic headache. He has used electrophysiological and imaging techniques to investigate the plasticity of the pain network in the development of chronic headache. He is a principal investigator on several of the large-scaled poplation based studies on predictors and risk factors of headache chronicity.    

    Dr Katsarava's interests relate to public health aspects of headache. He is working for international collaborations together with the WHO in raising awareness of the burdens attributable to headache in the countries of Eastern Europe and in improving access to headache-related healthcare in order to mitigate these burdens. He has published widely in refereed journals and elsewhere over 15 years.

    Disclosures
    President, EHF; Chairman, Lifting the Burden; Speaker for Allergan, Merck, Lilly, Teva and Novartis


Secondary Headaches:
 
  • Guus G Schoonman (Netherlands)
    Institution: ETZ Tilburg
    Country: Netherlands

    Guus Schoonman is working at the Neurology Department of the Leiden University Medical Centre. He obtained his MD in 2000 and his PhD in 2008 for the study of trigger factors in migraine. His main research focus is the pathophysiology of migraine in relation to the exposure of trigger factors. 

    Since 2001 he has served on the IHS Trainees and Residents committee and in 2010 he was appointed Chairman of the Education committee. Educational programmes are continuously provided, including the ‘online learning centre', the ‘headache master school' and ‘visiting professors'. And to set a standard for headache education, the IHS has created a Core Curriculum.

    Disclosures
    Principle Investigator Tilburg, Evolve 2 study Eli Lilly

     

WORKING GROUP CHAIRS
Women's Leadership Forum:

 
  • Gisela M Terwindt (Netherlands)
    Institution: Leiden University Medical Centre
    Country: Netherlands

    Gisela Terwindt received her MSc in Biology and MD in Medicine at the University of Leiden, the Netherlands. Her PhD encompassed epidemiology and genetics of migraine, with the discovery of the first migraine gene. She is associate professor of Neurology, and Consultant Neurologist, at the Department of Neurology, Leiden University Medical Center (LUMC), Netherlands, where she also runs the Headache Clinic.

    Gisela Terwindt is chair of the scientific committee of the Dutch Headache Society. She is member of the International Headache Classification Committee, the IHS Ethics Committee, and chair of the IHS Women’s Leadership Forum.

    She has published >150 scientific papers and several book chapters on headache and migraine.  She received a prestigious personal grant from the Dutch Organisation of Scientific Research (VIDI-award).

    Disclosures

    Gisela Terwindt reports  independent support from NWO, European Community, and the Dutch Heart Foundation.


 

AFFILIATE MEMBER SOCIETY REPRESENTATIVES
Argentina:
Pablo Schubaroff
Australia:
Alessandro Zagami
Austria:
Gregor Brössner
Azerbaijan:
Alishir Veys Musayev
Belgium:
Delphine Magis
Brazil:
Mauro Jurno
Bulgaria:
Ivan Milanov
Canada:
Elizabeth Leroux
China:
Shengyuan Yu
Colombia:
Joe Fernando Munoz Ceron
Czech Republic:
David Dolezil
Denmark:
Messoud Ashina
Egypt:
Khaled El Borolossy
Estonia:
Mark Braschinsky
France:
Dominique Valade
Georgia:
Zaza Katsarava
Germany:
Charly Gaul
Greece:
Dimos Mitsikostas
Guatemala:
Arla Cinderella Stokes Brackett
Hungary:
Delia Szok
India:
K Ravishankar
Iran:
Hossein Ansari
Italy (SISC):
Paola Sarchielli
Italy (ANIRCEF):
Fabio Frediani
Japan:
Koichi Hirata
Kyrgyzstan:
Kunduz Karbozova
Latvia:
Daina Jegere
Lithuania:
Antanas Vaitkus
Mexico:
Maria Karina Velez Jimenez
Moldova:
Stela Odobescu
Myanmar:
Hnin Wint Wint Aung
Netherlands:
Antoinette Maassen van den Brink
Norway:
Espen Saxhaug Kristoffersen
Pakistan:
Ahsan Numan
Peru:
Ernesto M Bancalari
Philippines:
Regina Macalintal-Canlas
Portugal:
Elsa Paixao Parreira
Republic of Korea:
Soo Jin Cho
Romania:
Adina Maria Roceanu
Russian Federation:
Alexey Sergeev
Serbia:
Srdjan Sretenovic
Singapore:
Jonathan Ong
Slovak Republic:
Peter Kukumberg
Slovenia:
Bojana Zvan
South Africa:
Elliot Shevel
Spain:
Patricia Pozo-Rosich
Sweden:
Lars Edvinsson
Switzerland:
Andreas Gantenbein
Taiwan:
Shuu-Jiun Wang
Turkey:
Aksel Siva
Ukraine:
Mykhaylo Oros
UK:
Fayyaz Ahmed
USA:
Allan Purdy
 

 

You need to be a member of the IHS to access this area of the website, please sign in to continue.

To find out more about membership types and how to join the IHS click onto the 'join' banner on the home page.

Close this box to continue.

Access to the Members Directory is restricted to Standard IHS members

Members Login

Your membership is currently shown as unpaid.

To renew your membership online click HERE.

Otherwise, please contact Carol Taylor to discuss your renewal.

This document is only available to members – please login.